ELIZABETH NOTHERN: Open Payments
NPI 1992052625 · CHANUTE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 64 payments from 16 companies in 2025. Trend: 2023 $466 · 2024 $486 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $267 |
| ABBVIE INC. | 26 | $229 |
| Amgen Inc. | 6 | $106 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| SHIELD THERAPEUTICS INC | 1 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| PFIZER INC. | 3 | $49 |
| SANOFI PASTEUR INC. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $20 |
Products named: VRAYLAR, FARXIGA, AIRSUPRA, XIFAXAN, OTEZLA, ACCRUFER, REXULTI, ELIQUIS.
Industry payments across KS — which companies pay providers there.
